On January 9, 2026, Cocrystal Pharma, Inc. approved the grant of stock options to its directors and certain executives, with total options granted amounting to 295,363 shares to various individuals, including cash awards. The stock options will begin to vest on January 9, 2027, and will be exercisable at the closing price on January 8, 2026.